Octreotide Market Report 2026

Octreotide Market Overview

• Octreotide market size has reached to $2.56 billion in 2025 • Expected to grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Rising Cancer Rates Fuel Growth In The Market • Market Trend: Innovations In Injectable Treatments For Enhanced Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Octreotide Market?

Octreotide is a synthetic somatostatin analog used to treat various medical conditions by inhibiting hormone secretion. Available in short-acting and long-acting formulations, it helps manage hormone-related disorders but may cause side effects such as gastrointestinal issues and gallstones. The main types of octreotide are octreotide acetate, octreotide, octreotide chloride, octreotide hydrochloride, and indium in-111 octreotide. Octreotide acetate is a synthetic analog of somatostatin used to treat hormone-secreting tumors, acromegaly, and severe diarrhea associated with certain cancers. These variants are available in various forms, including injections, powders, and microspheres, and are prescribed for conditions such as diarrhea, acromegaly, and other related indications. The distribution channels for octreotide include hospital pharmacies, online pharmacies, and retail pharmacies, with end-users primarily in the pharmaceutical and clinical research sectors.

What Is The Octreotide Market Growth Forecast?

The octreotide market size is expected to see steady growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to growth in long-acting injectable demand, increasing prevalence of endocrine disorders, expansion of oncology indications, rising hospital infusion capacity, innovation in sustained-release formulations. Major trends in the forecast period include increasing use in hormonal disorder management, growing adoption of long-acting injectable formulations, expansion in neuroendocrine tumor treatment, rising demand for hospital-administered therapies, increased focus on symptom control in chronic conditions.

Global Octreotide Market Segmentation

1) By Type: Octreotide Acetate, Octreotide, Octreotide Chloride, Octreotide Hydrochloride, Indium In-111 Octreotide 2) By Form: Injection, Powder, Microspheres 3) By Indications: Diarrhea, Acromegaly, Other Indications 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End-user: Pharmaceutical, Clinical Research Subsegments: 1) By Octreotide Acetate: Injectable Formulation, Depot Injectable Formulation 2) By Octreotide: Injectable Formulation, Oral Formulation 3) By Octreotide Chloride: Injectable Formulation, Lyophilized Powder 4) By Octreotide Hydrochloride: Injectable Formulation, Lyophilized Powder 5) By Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation, Therapeutic Radiopharmaceutical Formulation

What Is The Driver Of The Octreotide Market?

The increasing rates of cancer are expected to propel the growth of the octreotide market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Increasing cancer rates are largely due to aging populations, environmental factors, lifestyle choices, and improved detection methods. Octreotide helps counter rising cancer rates by inhibiting tumor growth, controlling hormone-related cancers, and alleviating associated symptoms. For instance, in May 2024, according to the reports published by the National Cancer Institute (NCI), a US-based government agency, there were nearly 20 million new cancer cases and 9.7 million deaths worldwide, with projections for 2040 rising to 29.9 million cases and 15.3 million deaths. Therefore, increasing rates of cancer are driving the growth of the octreotide industry.

Key Players In The Global Octreotide Market

Major companies operating in the octreotide market are Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, BCN Peptides S.A.

Global Octreotide Market Trends and Insights

Major companies operating in the octreotide market are focusing on developing innovative products, such as injectable suspensions, to improve patient adherence and convenience. Injectable suspensions are fast-acting medications that are administered via injection, allowing for quicker absorption into the bloodstream and bypassing the digestive system for faster onset of action. For instance, in October 2024, Teva Pharmaceuticals, an Israel-based pharmaceutical company, launched the generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), designed to be injected for fast absorption into the bloodstream. Octreotide is a synthetic analog of the natural hormone somatostatin and is primarily used to treat conditions such as acromegaly, carcinoid syndrome, and VIP-secreting tumors. The injectable delivery method allows for a quicker onset of action compared to traditional oral tablets, making it easier for patients to adhere to their treatment plans.

What Are Latest Mergers And Acquisitions In The Octreotide Market?

In April 2023, Chiesi Farmaceutici S.p.A., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed amount. This strategic acquisition allows Chiesi to broaden its portfolio in the rare disease sector, further strengthening its capacity to offer groundbreaking treatments. Additionally, the deal enhances Chiesi's efforts to improve patient access to transformative therapies for rare and complex conditions. Amryt Pharma Plc is an Ireland-based biopharmaceutical company that specializes in developing and commercializing octreotide-based treatments for rare and orphan diseases.

Regional Insights

North America was the largest region in the octreotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Octreotide Market?

The octreotide market consists of sales of short-acting octreotide formulations, long-acting octreotide formulations, and other extended-release formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Octreotide Market Report 2026?

The octreotide market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the octreotide industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.